[1]
|
Salley, K.E., Wickham, E.P., Cheang, K.I., Essah, P.A., Karjane, N.W. and Nestler, J.E. (2007) Glucose intolerance in polycystic ovary syndrome—A position statement of the Androgen Excess Society. The Journal of Clinical Endocrinology and Metabolism, 92, 4546-4556.
http://dx.doi.org/10.1210/jc.2007-1549
|
[2]
|
Moran, L.J., Misso, M.L., Wild, R.A., Norman, R.J. (2010) Impaired glucose tolerance, Type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update, 16, 347-363. http://dx.doi.org/10.1093/humupd/dmq001
|
[3]
|
Wild, R.A., Carmina, E., Diamanti-Kandarakis, E., Dokras, A., Escobar-Morreale, H.F., Futterweit, W., Lobo, R., Norman, R.J., Talbott, E. and Dumesic, D.A. (2010) Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. The Journal of Clinical Endocrinology and Metabolism, 95, 2038-2049. http://dx.doi.org/10.1210/jc.2009-2724
|
[4]
|
Levy, J.C., Matthews, D.R. and Hermans, M.P. (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program[J]. Diabetes Care, 21, 2191-2192. http://dx.doi.org/10.2337/ diacare.21.12.2191
|
[5]
|
Burghen, G.A., Givens, J.R. and Kitabchi, A.E. (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. The Journal of Clinical Endocrinology and Metabolism, 50,113-116.
http://dx.doi.org/10.1210/jcem-50-1-113
|
[6]
|
Dunaif, A. and Thomas, A. (2001) Current Concepts in the polycystic ovary syndrome. Annual Review of Medicine, 52, 401-404.
http://dx.doi.org/10.1146/annurev.med.52.1.401
|
[7]
|
Lin, T.C., Yen, J.M., Gong, K.B., et al. (2006) Abnormal glucose tolerance and insulin resistance in polycystic ovary syndrome amongst the Taiwanese populationnot correlated with insulin receptor substrate-1 Gly972Arg/ Ala513Pro polymorphism. BMC Medical Genetics, 7, 36-38. http://dx.doi.org/10.1186/1471-2350-7-36
|
[8]
|
Fruzzetti, F., Perini, D., Lazzarini, V., et al. (2009) Hyperandrogenemia influences the prevalence of the metabolic syndrome abnormalities in adolescents with the polycystic ovary syndrome. Gynecological Endocrinology, 25, 335-343. http://dx.doi.org/10.1080/09513590802630146
|
[9]
|
Ghazeeri, G., Kutteh, W.H., Bryer-Ash, M., et al. (2003) Effect of rosiglitazone on spontaneous and clomiphene citrate-induced ovulation in women with polycystic ovary syndrome. Fertility and Sterility, 79, 562-566.
http://dx.doi.org/10.1016/S0015-0282(02)04843-4
|